Elevance Health Inc. (ELV) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Elevance Health Reports Second Quarter 2022 Results, Raises Full Year Outlook
July 20, 2022 6:00 AM EDTSecond quarter GAAP net income was $6.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $8.04* per share. Operating revenue grew 15.6% over the prior year quarter to $38.5 billion. Operating gain grew 13.7% over the prior year quarter to $2.4 billion. Medical enrollment increased 2.7 million members year-over-year and 276 thousand members during the quarter to 47.1 million members. Third quarter 2022 dividend of $1.28 per share declared to shareholders.
INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported second quarter 2022 results reflecting strong... More



